Protein Supplementation During Luteal Phase to Stop Protein Degradation
Sam Houston State University · NCT07843095
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–35 · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 34
- US sites recruiting
- 1
- Study start
- August 4, 2026
- Record last updated
- September 25, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this research is to determine if increasing 12% of daily protein intake during the luteal phase mitigates the potential catabolic effects of progesterone on skeletal muscle. We anticipate there will be an advantageous, decreased catabolic effect with increasing protein intake during the luteal phase.
By doing this study, we hope to learn if millions of women would benefit from additional protein supplementation during the luteal phase, which may lead to decreased skeletal muscle atrophy over time. Your participation in this research will last about 4 months.
Being studied: protein supplement; Placebo
Conditions: Muscle Atrophy
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Eumenorrheic
- 18 to 35 years old
Exclusion Criteria
- Pregnant or lactating (These individuals will not have a regular menstrual cycle) in the previous six months
- Vegetarian (protein supplementation is from animal origin)
- Contraceptive use, any hormone based contraceptive use for 6 months prior to enrollment
- Use of illicit drugs in previous 6 months.
- Non-tobacco user
- Gasterointestinal disorders, liver disease, infectious disease, cardiovascular, pulmonary, renal, immune, metabolic, cancer
- Medications: corticosteroids, chronic NSAIDS, high strength acne, testosterone
- Diagonsed PCOS, endometrosis, ovarian insufficency, or other menstrual cycle disorder.
Recruiting US locations
SHSU College of Osteopathic Medicine
Conroe, TX 77304
Site contact: Kyndal Kutac · 979-743-1135 · kbk016@shsu.edu
Study contacts (from the official record)
- Kyndal Kutac · 979-743-1135 · kbk016@shsu.edu
- Damian Chiandussi, MD · dac150@shsu.edu
Similar studies in Texas
All healthy volunteers studies in Texas →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of LY4355756 in Healthy Participants
Eli Lilly and Company
- Location
- Dallas, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- San Antonio, TX + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
Eli Lilly and Company
- Location
- San Antonio, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Radiprodil in Participants With Hepatic Impairment
GRIN Therapeutics, Inc.
- Location
- DeSoto, TX + 1 other US site
- Eligibility basics
- Ages 18–75